These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3802248)

  • 21. [Sensitivity and efficiency of intrathecal IgG secretion in multiple sclerosis. Comparison of several indices and formulas using pre-established values of specificity].
    Cordero M; Viñuela F; Angulo S; Martínez-Parra C; Izquierdo G
    Neurologia; 1997; 12(7):277-80. PubMed ID: 9432195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Disorders in the function of the blood-brain barrier in multiple sclerosis].
    Sachs B; Zimmermann K
    Z Arztl Fortbild (Jena); 1981 Oct; 75(19):889-91. PubMed ID: 7314678
    [No Abstract]   [Full Text] [Related]  

  • 23. Cerebrospinal fluid immunoglobulins and the central nervous system as an immunological organ particularly in multiple sclerosis and subacute sclerosing panencephalitis.
    Tourtellotte WW
    Res Publ Assoc Res Nerv Ment Dis; 1971; 49():112-55. PubMed ID: 4107848
    [No Abstract]   [Full Text] [Related]  

  • 24. Central nervous system involvement in early syphilis. Part 1. Intrathecal immunoglobulin production.
    Löwhagen GB; Andersson M; Blomstrand C; Roupe G
    Acta Derm Venereol; 1983; 63(5):409-17. PubMed ID: 6197840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of multiple sclerosis using immunosuppression. Critical discussion of results].
    Hommes OR
    Ned Tijdschr Geneeskd; 1976 Mar; 120(10):424-30. PubMed ID: 765862
    [No Abstract]   [Full Text] [Related]  

  • 26. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis.
    Tourtellotte WW; Ma BI
    Neurology; 1978 Sep; 28(9 Pt 2):76-83. PubMed ID: 362237
    [No Abstract]   [Full Text] [Related]  

  • 28. CD4 T cell activation and disease activity at onset of multiple sclerosis.
    Jensen J; Langkilde AR; Fenst C; Nicolaisen MS; Roed HG; Christiansen M; Sellebjerg F
    J Neuroimmunol; 2004 Apr; 149(1-2):202-9. PubMed ID: 15020081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The blood-brain barrier in neuroinflammatory diseases.
    de Vries HE; Kuiper J; de Boer AG; Van Berkel TJ; Breimer DD
    Pharmacol Rev; 1997 Jun; 49(2):143-55. PubMed ID: 9228664
    [No Abstract]   [Full Text] [Related]  

  • 30. Value of central nervous system IgG daily synthesis determination in the diagnosis of multiple sclerosis.
    Mandler R; Goren H; Valenzuela R
    Neurology; 1982 Mar; 32(3):296-8. PubMed ID: 7199643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intrathecal IgG synthesis: when is determination of oligoclonal bands necessary?].
    Kaiser R; Czygan M; Kaufmann R; Lücking CH
    Nervenarzt; 1995 Aug; 66(8):618-23. PubMed ID: 7566274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring IgG production within the central nervous system.
    Schuller E; Sagar HJ
    Ann Neurol; 1986 Sep; 20(3):373-4. PubMed ID: 3767323
    [No Abstract]   [Full Text] [Related]  

  • 33. The basis of intra-blood-brain-barrier IgG synthesis.
    Tourtellotte WW; Staugaitis SM; Walsh MJ; Shapshak P; Baumhefner RW; Potvin AR; Syndulko K
    Ann Neurol; 1985 Jan; 17(1):21-7. PubMed ID: 3985581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate.
    Tourtellotte WW; Potvin AR; Fleming JO; Murthy KN; Levy J; Syndulko K; Potvin JH
    Neurology; 1980 Mar; 30(3):240-4. PubMed ID: 7189023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microglia, macrophages and the blood-brain barrier.
    Graeber MB
    Clin Neuropathol; 1993; 12(5):296-7. PubMed ID: 8222403
    [No Abstract]   [Full Text] [Related]  

  • 36. Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity.
    Hirohata S; Hirose S; Miyamoto T
    Arch Intern Med; 1985 Oct; 145(10):1843-6. PubMed ID: 3899036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF immunoglobulins G in multiple sclerosis.
    Caputo D; Zaffaroni M; Procaccia S
    Boll Ist Sieroter Milan; 1982; 61(5):393-403. PubMed ID: 6927183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcortical and cortical somatosensory evoked potentials: characteristic waveform changes associated with disorders of the peripheral and central nervous system.
    Jones SJ; Halliday AM
    Adv Neurol; 1982; 32():313-20. PubMed ID: 6798846
    [No Abstract]   [Full Text] [Related]  

  • 39. Azathioprine reduces intrathecal IgG synthesis in multiple sclerosis.
    Caputo D; Zaffaroni M; Ghezzi A; Cazzullo CL
    Acta Neurol Scand; 1987 Feb; 75(2):84-6. PubMed ID: 3577680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoelectric focusing and immunofixation of cerebrospinal fluid oligoclonal IgG in neurological disorders.
    Rubin DB; Mehta PD; Nathanson M
    Diagn Immunol; 1985; 3(3):160-2. PubMed ID: 4053495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.